BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17095511)

  • 1. Activation of TRPM7 channels by phospholipase C-coupled receptor agonists.
    Langeslag M; Clark K; Moolenaar WH; van Leeuwen FN; Jalink K
    J Biol Chem; 2007 Jan; 282(1):232-9. PubMed ID: 17095511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated regulation of the TRPM7 channel through its endogenous protein kinase domain.
    Takezawa R; Schmitz C; Demeuse P; Scharenberg AM; Penner R; Fleig A
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6009-14. PubMed ID: 15069188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRPM7 channel is inactivated by PIP(2) hydrolysis.
    Runnels LW; Yue L; Clapham DE
    Nat Cell Biol; 2002 May; 4(5):329-36. PubMed ID: 11941371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPM7, the Mg(2+) inhibited channel and kinase.
    Bates-Withers C; Sah R; Clapham DE
    Adv Exp Med Biol; 2011; 704():173-83. PubMed ID: 21290295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells.
    Yogi A; Callera GE; Tostes R; Touyz RM
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R201-7. PubMed ID: 18799634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells.
    Callera GE; He Y; Yogi A; Montezano AC; Paravicini T; Yao G; Touyz RM
    J Hypertens; 2009 Jan; 27(1):155-66. PubMed ID: 19145781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.
    Schäfer S; Ferioli S; Hofmann T; Zierler S; Gudermann T; Chubanov V
    Pflugers Arch; 2016 Apr; 468(4):623-34. PubMed ID: 26669310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels.
    Inoue K; Branigan D; Xiong ZG
    J Biol Chem; 2010 Mar; 285(10):7430-9. PubMed ID: 20048154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPM7 involvement in cancer: a potential prognostic factor.
    Dhennin-Duthille I; Gautier M; Korichneva I; Ouadid-Ahidouch H
    Magnes Res; 2014; 27(3):103-12. PubMed ID: 25367030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.
    Jiang J; Li MH; Inoue K; Chu XP; Seeds J; Xiong ZG
    Cancer Res; 2007 Nov; 67(22):10929-38. PubMed ID: 18006838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels.
    Sun Y; Selvaraj S; Varma A; Derry S; Sahmoun AE; Singh BB
    J Biol Chem; 2013 Jan; 288(1):255-63. PubMed ID: 23168410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase.
    Deason-Towne F; Perraud AL; Schmitz C
    Cell Signal; 2012 Nov; 24(11):2070-5. PubMed ID: 22759789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.
    Visser D; Langeslag M; Kedziora KM; Klarenbeek J; Kamermans A; Horgen FD; Fleig A; van Leeuwen FN; Jalink K
    Cell Calcium; 2013 Dec; 54(6):404-15. PubMed ID: 24176224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of a Mg2+-inhibited K+ current and a TRPM7-like current in human erythroleukemia cells.
    Mason MJ; Schaffner C; Floto RA; Teo QA
    Am J Physiol Cell Physiol; 2012 Mar; 302(6):C853-67. PubMed ID: 22135214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.
    Rybarczyk P; Gautier M; Hague F; Dhennin-Duthille I; Chatelain D; Kerr-Conte J; Pattou F; Regimbeau JM; Sevestre H; Ouadid-Ahidouch H
    Int J Cancer; 2012 Sep; 131(6):E851-61. PubMed ID: 22323115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPM7 Upregulate the Activity of SMAD1 through PLC Signaling Way to Promote Osteogenesis of hBMSCs.
    Hong F; Wu S; Zhang C; Li L; Chen J; Fu Y; Wang J
    Biomed Res Int; 2020; 2020():9458983. PubMed ID: 32596398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.
    Gautier M; Perrière M; Monet M; Vanlaeys A; Korichneva I; Dhennin-Duthille I; Ouadid-Ahidouch H
    Curr Med Chem; 2016; 23(36):4092-4107. PubMed ID: 27604090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct calcium regulation of TRPM7 mechanosensitive channels at plasma membrane microdomains visualized by FRET-based single cell imaging.
    Starostina I; Jang YK; Kim HS; Suh JS; Ahn SH; Choi GH; Suk M; Kim TJ
    Sci Rep; 2021 Sep; 11(1):17893. PubMed ID: 34504177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that TRPM7 is required for breast cancer cell proliferation.
    Guilbert A; Gautier M; Dhennin-Duthille I; Haren N; Sevestre H; Ouadid-Ahidouch H
    Am J Physiol Cell Physiol; 2009 Sep; 297(3):C493-502. PubMed ID: 19515901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PLC-delta1 by Gi/o-coupled receptor agonists.
    Murthy KS; Zhou H; Huang J; Pentyala SN
    Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1679-87. PubMed ID: 15525688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.